New President Obama has moved quickly to get Stem Cell research underway following up on an election promise to review previous adminisatrations' inability to support medical research.
Geron, a biotechnology company, had sought permission to conduct clinical trials for spinal cord injuries, using paraplegic patients, the stem cell to stimulate nerve cells into action.
The Federal Drug regulators, following a review of a 22,000 page report, finally gave permision Friday, January 23.
From the basis of this stem cell research, further investigation by Geron Biotech may result in some help to cancer and brain tumor patients.
In the last couple of years, attention has turned away from embryonic stem cells to a newer technique that allows for the patient's own skin cells to be turned into a cell resembling embryonic cells. Acknowledgment New York Times. Geoff
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment